Gibt es Studien zur Isoflavonwirkung bei Osteoporose?

Studien zur Isoflavonwirkung bei der Osteoporose:

Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab. 2003 Oct;88(10):4740-7

The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2004 Feb;79(2):326-33

Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause. 11(3):246-254, 2004

Effects of Estrogen-Progestin on Risk of Fracture and Bone Mineral Density. JAMA. 2003;290:1729-1738

Soy Protein Has a Greater Effect on Bone in Postmenopausal Women Not on Hormone Replacement Therapy, as Evidenced by Reducing Bone Resorption and Urinary Calcium Excretion. The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 3 1048-1054

Effects of Phytoestrogens on Bone Turnover in Postmenopausal Women with a History of Breast Cancer. The Journal of Clinical Endocrinology and Metabolism Vol. 89, No. 3 1207-1212

Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr. 2000 Jul;130(7):1675-81

The Soybean Isoflavone Genistein Induces Differentiation of MG63 Human Osteosarcoma Osteoblasts.. Journal of Nutrition. 2006 May;136(5):1166-70

Soy isoflavones attenuate bone loss in early postmenopausal Chinese women : A single-blind randomized, placebo-controlled trial.. Eur J Nutr. 2006 Jun 8